Actelion Pharmaceuticals Ltd. (Actelion)

Oncology Corporate Profile

HQ Location

Gewerbestrasse 16
CH-4123 Allschwil, Switzerland

Company Description

Actelion is a biopharmaceutical company focused on the discovery, development and commercialization of smallmolecule drugs as innovative treatments to serve high unmet medical needs. The company has its corporate headquarters in Allschwil/Basel, Switzerland where it was founded in 1997.

Website: http://www.actelion.com

Brand Generic Indication
Valchlor__¢mechlorethamineVALCHLOR is an alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides_Ê_type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
macitentanendothelin receptor antagonist (ERA)Glioblastoma Multiforme (GBM)I

Source


http://www.actelion.com

Recent News Headlines

There are no news items to display